1-Adamantanamine CAS 768-94-5; Puritas >98.0% (GC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 1-Adamantanamine (CAS: 768-94-5) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com
Nomen chemicum | 1-Adamantanamine |
Synonyma | Amantadine;1-Aminoadamantane;1-Adamantylamine;Adamantan-1-Amine;Tricyclo [3.3.1.13,7] decanatum-1-amine |
CAS Number | 768-94-5 |
CATTUS Number | RF-PI2286 |
Stock Status | In Stock, Productio Capacity 20 MT/Month |
Formulae hypotheticae | C10H17N |
M. Pondus | 151.25 |
Density | 1.066 g/cm3 |
Sensitiva | Aer Sensitiva |
Solubilitas (Solubile in) | Methanol;Solutum in Organicis Solventibus.Insolubilis in aqua |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad lux Yellow vel Crystal |
Puritas / Analysis Methodus | >98.0% (GC) |
Puritas / Analysis Methodus | 97.5~ 102.5% (Titration by HClO4) |
Liquescens punctum | 207.0~209.0℃ |
Humor (KF) | <0.50% |
Residere in Ignition | <0.50% |
Totalis immunditias | <2.00% |
Solubilitas in 1 N HCl | Hyalina ut Fain Yellow, patet ad leviter nebula V% Tempus |
Infrared Imaginis | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
1-Adamantanamine, qui etiam cognomento Amantadine vel 1-Aminoadamantane vel 1-Adamantylamine (CAS: 768-94-5) fungitur catalyst in enantioselectivo stretrico phosphinoyl imines reactionem.Utile etiam est ad synthesim derivatorum adamantani, hoc est Amantadine hydrochloridi.1-Adamantanamine membrum est classis adamantanarum quae in pharmaceutica industria uti antivirali et antiparkinsoniana medicamento adhibetur.Curatio Parkinsonismi cum Levodopa, medicamentis anticholinergicis et amantadine, meliores proventus praebet quam singulis his medicamentis utens.Imbecillus adversario NMDA receptoris glutamatis est, qui emissionem dopaminis augere potest et restitutionem dopaminis obstruere.Medicamentum etiam emissionem norepinephrine a nervi terminationibus in cerebro promovere potest.Dyskinesiam morbo Parkinson tractare potest et post longum tempus curationis dopaminergicae dyskinesiam emendare potest.